Professional Documents
Culture Documents
2. Sepsis is not considered an epidemic disease but a medical emergency with a global impact.
4. Significant infectious challenges in the 21st century include antibiotic resistance, emerging
pathogens, and healthcare-associated infections.
5. Sepsis is a global health problem due to its high mortality rates, long-term consequences for
survivors, and the increasing prevalence of antibiotic-resistant infections.
6. Factors contributing to sepsis development include weakened immune systems, chronic illnesses,
and invasive medical procedures.
7. Organs and systems that may become the primary focus of sepsis include the lungs, abdominal
organs, skin, kidneys, and oropharynx.
8. Microorganisms causing sepsis may necessitate invasive interventions for diagnosis and treatment.
9. Stages of sepsis development include infection, systemic inflammatory response syndrome (SIRS),
sepsis, severe sepsis, and septic shock.
10. Links in sepsis pathological process involve an initial infection, inflammatory response, and
subsequent organ dysfunction.
11. Clinical features of SIRS include fever, increased heart rate, respiratory rate, and abnormal white
blood cell count.
12. Clinical features of septic shock include low blood pressure, despite adequate fluid resuscitation,
and signs of organ dysfunction.
13. Stages of sepsis pathogenesis include infection, bacteremia, systemic inflammation, and organ
dysfunction.
14. "Cytokine storm" refers to an excessive immune response, releasing a large number of
inflammatory molecules.
15. The sequence of inflammation development involves recognition of pathogens, activation of
immune cells, and release of inflammatory mediators.
16. Forms of sepsis based on etiology, entrance gate, primary focus localization, and clinical course
offer different classification perspectives.
17. Common clinical manifestations include fever, hypotension, altered mental status, and signs of
organ dysfunction.
18. Clinical manifestations of liver damage may include jaundice and abnormal liver function tests.
19. Clinical manifestations of renal damage may involve decreased urine output and elevated
creatinine levels.
20. Clinical manifestations of spleen damage are less specific but may include pain and enlargement.
21. Clinical manifestations of CNS damage range from confusion to seizures and coma.
22. Typical blood test findings in sepsis include elevated white blood cell count, procalcitonin, and
inflammatory markers.
23. Clinical features of acute sepsis encompass rapid onset of symptoms, often progressing to severe
illness.
25. General diagnostic criteria for sepsis include clinical signs of infection and evidence of organ
dysfunction.
26. Laboratory findings confirming sepsis include positive blood cultures and elevated inflammatory
markers.
27. Organ dysfunction manifestations can include respiratory failure, cardiovascular collapse, and
renal failure.
29. Dysfunction of two or more organ systems can confirm the diagnosis of sepsis.
30. Culture studies may not confirm the infectious agent in 100% of cases.
31. Blood sampling rules include obtaining cultures before starting antibiotics.
32. Treatment of sepsis involves supportive care, source control, and antimicrobial therapy.
33. The qSOFA Scale assesses quick Sequential Organ Failure Assessment parameters to identify
patients at risk of poor outcomes.
34. Factors assessed before starting empirical therapy include patient history, local antimicrobial
resistance patterns, and clinical presentation.
35. Antibacterial therapy should be started as soon as sepsis is suspected.
36. The maximum coverage of the potential causative agent with empirical therapy is achieved
within the first few hours.
37. The choice of drug depends on the suspected pathogen, patient allergies, and local resistance
patterns.
38. Antibiotic therapy started after 36 hours can still be effective for patient survival.
40. The minimal time to assess the efficiency of antibiotic therapy is within the first 48 hours.
41. Decision to change antimicrobial drugs depends on clinical response, culture results, and adverse
effects.
44. The course of antibiotic therapy varies but is typically 7-14 days.
45. Antibiotic therapy can be discontinued when the patient is clinically stable.
46. Generally administered agents include broad-spectrum antibiotics, antifungals, and antivirals.
47. Optimal pathogenetic therapy includes fluid resuscitation, vasopressors, and supportive care.
48. Prevention of sepsis involves infection control measures, vaccination, and early recognition of
infections.